glp 1 journal GLP-1-based therapies for diabetes, obesity and beyond GLP-1 Weight Loss Journal &

Medical-grade GLP-1 agonist with expert physician guidance and personalized weight loss programs.

The rise of prescription medications used for weight loss has reshaped conversations about employer-sponsored health benefits and raised many new questions for employers

Medications are shipped directly to patients with transparent pricing and ongoing provider support

Yi, a bariatric surgeon, cuts through the noise on GLP-1 medications for men

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

The FDA recently approved versions of GLP-1 medication - including Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) - for chronic weight management